ADAR1 Capital Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Buy |
67,813
+8,400
| +14% | +$223K | 0.28% | 55 |
|
|
2025
Q1 | $1.43M | Buy |
59,413
+50,113
| +539% | +$1.21M | 0.27% | 63 |
|
|
2024
Q4 | $374K | Buy |
9,300
+2,200
| +31% | +$88.5K | 0.07% | 116 |
|
|
2024
Q3 | $450K | Sell |
7,100
-84,127
| -92% | -$5.33M | 0.07% | 113 |
|
|
2024
Q2 | $4.84M | Buy |
91,227
+76,826
| +533% | +$4.07M | 0.91% | 19 |
|
|
2024
Q1 | $1.18M | Sell |
14,401
-239,750
| -94% | -$19.7M | 0.27% | 50 |
|
|
2023
Q4 | $4.73M | Buy |
+254,151
| New | +$4.73M | 1.69% | 12 |
|